Herb reference

Brahmi

Bacopa monnieri (L.) Pennell

Crystalis is a reference resource for herbal, crystal, and somatic practice.

This library is designed to help readers orient, compare, and research. It is not a substitute for medical care or practitioner judgment.

Botanical / editorial

Family
Plantaginaceae
Plant type
perennial creeping herb
Route
Mixed route
Evidence tier
Mixed evidence
Indian subcontinent, Southeast Asia, Australia3000+Plantaginaceae

Botanical / meta

Botanical identity

Botanical description

Brahmi is a small, creeping perennial herb with succulent stems and pairs of small, oblong, light green leaves arranged oppositely along the stem. It produces tiny, five-petaled white or pale purple flowers with yellow centres. The entire aerial portion is used medicinally; it thrives in moist, marshy environments and can grow submerged in water.

Pharmacognosy intro

Brahmi contains dammarane-type triterpenoid saponins collectively known as bacosides (bacoside A, bacoside B), which are considered the primary active constituents and comprise up to 38% of standardized extracts. Other key compounds include bacopasaponins (bacopasaponin C, D), bacopaside I–II, bacosine, and the alkaloids brahmine and herpestine. The herb also contains D-mannitol, apigenin, luteolin, quercetin, β-sitosterol, and stigmasterol. Bacosides have been extensively studied in preclinical models for neuroprotective, antioxidant, and adaptogenic effects. The herb also exhibits acetylcholinesterase inhibitory activity and may influence serotonin and dopamine signalling.

Editorial orientation

The practical read

Body-first read

What it is for

Brahmi contains dammarane-type triterpenoid saponins collectively known as bacosides (bacoside A, bacoside B), which are considered the primary active constituents and comprise up to 38% of standardized extracts. Other key compounds include bacopasaponins (bacopasaponin C, D), bacopaside I–II, bacosine, and the alkaloids brahmine and herpestine. The herb also contains D-mannitol, apigenin, luteolin, quercetin, β-sitosterol, and stigmasterol. Bacosides have been extensively studied in preclinical models for neuroprotective, antioxidant, and adaptogenic effects. The herb also exhibits acetylcholinesterase inhibitory activity and may influence serotonin and dopamine signalling.

Route panel

Preparation shapes the claim

Evidence and safety may differ by preparation. Essential oil, tea, tincture, extract, infused oil, and topical use are not interchangeable.

Mixed route

Quality

Fresh, dried, oil, and garden read

Growing tips

Brahmi thrives in moist, humid conditions with full to partial sun. It can be grown in shallow water, bog gardens, or moist soil. Propagate by stem cuttings placed in water or moist substrate. It is frost-sensitive and should be grown as an annual or container plant in cooler climates. Harvest aerial parts during the flowering period for maximum bacoside content.

Quality notes

Standardized extracts should contain a minimum of 20–50% bacosides (typically bacoside A) for therapeutic consistency. Whole dried herb is also used in traditional preparations. The herb has a slightly bitter taste. Look for products that specify bacoside content and are third-party tested for heavy metals. Brahmi is sometimes adulterated with Centella asiatica (gotu kola), which is also called "brahmi" in some regions — verify species identity on the label.

Companion

Crystal pairing reference

Crystal side

Companion crystal

The deeper layer

Compound and clinical layer

Clinical and compound notes are included as a research layer, not as treatment instructions.

Safety intro

Brahmi has a high safety profile when used at standard doses (300–600 mg extract daily). The most commonly reported adverse effects are mild gastrointestinal symptoms (nausea, bloating, increased stool frequency). Brahmi inhibits several cytochrome P450 isoenzymes (CYP2C9, CYP2C19, CYP1A2, CYP2D6, CYP3A4) and may interact with drugs metabolised by these pathways. Case reports document interactions: concurrent use with agomelatine caused back pain and hyperhidrosis; concurrent use with moclobemide was associated with myocardial infarction; and concurrent use with cevimeline caused cholinergic toxicity symptoms (sweating, malaise, nausea, tachycardia) in a patient with Sjogren's syndrome. Use caution when combining with antidepressants, anticholinergics, or sedative medications. Discontinue at least 2 weeks before surgery. Safety during pregnancy and lactation has not been adequately established; avoid use beyond food amounts.

Questions

Frequently asked about Brahmi

What are the safety concerns and drug interactions for brahmi?

Brahmi (Bacopa monnieri) has a high safety profile at standard doses, with the most common adverse effects being mild gastrointestinal symptoms such as nausea, bloating, and increased stool frequency. The interaction concern is enzymatic: brahmi inhibits several cytochrome P450 isoenzymes (CYP2C9, CYP2C19, CYP1A2, CYP2D6, CYP3A4), demonstrated for the standardized extract and its constituents (Ramasamy et al., 2014), so it can alter levels of drugs cleared by these pathways. Documented case reports include back pain and hyperhidrosis with agomelatine, a myocardial infarction with moclobemide, and cholinergic toxicity with cevimeline, so caution applies with antidepressants, anticholinergics, and sedatives. Discontinue at least two weeks before surgery, and avoid beyond food amounts in pregnancy and lactation given inadequate data.

How is brahmi prepared and dosed?

Brahmi is most commonly taken as a standardized extract delivering 300-600 mg daily, typically standardized to its bacoside content, the dammarane-type triterpenoid saponins that can reach up to 38% of a standardized extract. It is a slow-building nootropic rather than an acute agent, with cognitive benefits in trials generally emerging over roughly 8-12 weeks of consistent use rather than from a single dose. Traditional Ayurvedic delivery includes the fresh juice and ghee-based preparations, and taking it with food helps blunt the mild gastrointestinal effects. Because the actives are saponins, products are best chosen by stated bacoside percentage rather than raw powder weight.

How do you evaluate brahmi quality?

Fresh brahmi is a small succulent creeping herb with thick, oval, bright-green leaves, and good fresh material looks plump and unblemished rather than yellowing. Dried herb should stay green-toned and faintly bitter, not brown and odorless. The most important quality marker for extracts is standardization to bacosides, since potency is driven by these triterpenoid saponins; a product that does not state a bacoside percentage is hard to dose meaningfully. Also confirm the species, because brahmi (Bacopa monnieri) is routinely confused in the market with gotu kola (Centella asiatica), an entirely different plant sometimes sold under the same common name.

How is brahmi (Bacopa) different from gotu kola, which shares the name?

Both are traditional brain tonics and both are loosely called brahmi in different regions, but they are unrelated plants with different chemistry. Bacopa monnieri owes its activity to dammarane-type triterpenoid saponins called bacosides, and it shows acetylcholinesterase-inhibiting activity plus effects on serotonin and dopamine signalling. Gotu kola (Centella asiatica) instead relies on triterpenes such as asiaticoside and madecassoside and is better known for connective-tissue and wound-healing effects. Confusing the two means dosing the wrong saponin profile entirely, so verifying Bacopa monnieri on the label and standardization to bacosides is what keeps the nootropic intent intact.

How should brahmi be stored and what is its shelf life?

Dried brahmi leaf stored in an airtight container away from heat, light, and moisture holds for roughly one to two years, though the bacoside saponins slowly degrade with prolonged moisture and light exposure. Standardized extract capsules generally hold labeled potency longer than loose-cut herb and are the more stable format. Fresh brahmi is perishable and is best refrigerated and used within a few days, or processed promptly into juice or extract. A batch that has browned and lost its faint bitterness has likely lost saponin content and should be replaced.

Sources & Citations

Where this entry can be checked

Peer-reviewed sources for the pharmacological and clinical claims on this page. Crystalis herb entries describe tradition and current research; they are reference, not medical advice.

  1. 01

    SCI

    Inhibition of Human Cytochrome P450 Enzymes by Bacopa monnieri Standardized Extract and Constituents

    Ramasamy S, et al. (2014). Inhibition of Human Cytochrome P450 Enzymes by Bacopa monnieri Standardized Extract and Constituents. Molecules. [SCI]DOI 10.3390/molecules19022588

Resource framing

Crystalis is a reference resource for herbal, crystal, and somatic practice.

This library is designed to help readers orient, compare, and research. It is not a substitute for medical care or practitioner judgment.

Clinical and compound notes are included as a research layer, not as treatment instructions.

Evidence and safety may differ by preparation. Essential oil, tea, tincture, extract, infused oil, and topical use are not interchangeable.